Filed: 8/14/2025ACC: 0001415889-25-021914
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 31 equity positions with a total reported market value of $1.33B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
31
Positions
$1.33B
Total AUM (reported)
130.79M
Total Shares
Allocation by class
COM$1.20B90.0%
COM NEW$109.73M8.2%
SPONSORED ADS$10.30M0.8%
CL A ORD SHS$7.96M0.6%
CLASS A ORD SHS$4.86M0.4%
ORD SHS$1.16M0.1%
Portfolio Concentration
Top 3$594.01M44.5%
4–10$400.82M30.0%
11–25$319.21M23.9%
Rest$20.40M1.5%
Top 3 weight
44.5%
Top 10 weight
74.6%
Voting Authority Distribution
Total shares with voting rights: 130.79M
Sole
Full voting authority
130.79M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole31
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings31
Rows:
APOGEE THERAPEUTICS INC
SOLEShares8.49M
TypeSH
Market value$368.86M
27.64%
Sole
8.49M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares12.76M
TypeSH
Market value$118.44M
8.88%
Sole
12.76M
Shared
0.00
None
0.00
METSERA INC
SOLEShares3.75M
TypeSH
Market value$106.71M
8.00%
Sole
3.75M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares4.03M
TypeSH
Market value$80.77M
6.05%
Sole
4.03M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares6.73M
TypeSH
Market value$76.07M
5.70%
Sole
6.73M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares6.60M
TypeSH
Market value$66.96M
5.02%
Sole
6.60M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.88M
TypeSH
Market value$54.28M
4.07%
Sole
3.88M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares4.15M
TypeSH
Market value$46.50M
3.48%
Sole
4.15M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares2.69M
TypeSH
Market value$40.20M
3.01%
Sole
2.69M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares2.05M
TypeSH
Market value$36.04M
2.70%
Sole
2.05M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares4.76M
TypeSH
Market value$34.14M
2.56%
Sole
4.76M
Shared
0.00
None
0.00
JADE BIOSCIENCES INC
SOLEShares3.22M
TypeSH
Market value$32.17M
2.41%
Sole
3.22M
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC
SOLEShares13.97M
TypeSH
Market value$31.71M
2.38%
Sole
13.97M
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares639.09K
TypeSH
Market value$31.13M
2.33%
Sole
639.09K
Shared
0.00
None
0.00
UPSTREAM BIO INC
SOLEShares2.30M
TypeSH
Market value$25.20M
1.89%
Sole
2.30M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares17.86M
TypeSH
Market value$22.68M
1.70%
Sole
17.86M
Shared
0.00
None
0.00
CRESCENT BIOPHARMA INC.
SOLEShares1.39M
TypeSH
Market value$22.40M
1.68%
Sole
1.39M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$20.70M
1.55%
Sole
2.17M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares8.88M
TypeSH
Market value$20.26M
1.52%
Sole
8.88M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares1M
TypeSH
Market value$18.63M
1.40%
Sole
1M
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
SOLEShares5.05M
TypeSH
Market value$18.37M
1.38%
Sole
5.05M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares2.46M
TypeSH
Market value$13.17M
0.99%
Sole
2.46M
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
SOLEShares1.38M
TypeSH
Market value$10.39M
0.78%
Sole
1.38M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares1.35M
TypeSH
Market value$10.30M
0.77%
Sole
1.35M
Shared
0.00
None
0.00
PERCEPTIVE CAP SOLUTIONS COR
SOLEShares750K
TypeSH
Market value$7.96M
0.60%
Sole
750K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APOGEE THERAPEUTICS INCSOLE | COM | 8.49M | SH | $368.86M 27.64% | 8.49M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 12.76M | SH | $118.44M 8.88% | 12.76M | 0.00 | 0.00 |
METSERA INCSOLE | COM | 3.75M | SH | $106.71M 8.00% | 3.75M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 4.03M | SH | $80.77M 6.05% | 4.03M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 6.73M | SH | $76.07M 5.70% | 6.73M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 6.60M | SH | $66.96M 5.02% | 6.60M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.88M | SH | $54.28M 4.07% | 3.88M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 4.15M | SH | $46.50M 3.48% | 4.15M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 2.69M | SH | $40.20M 3.01% | 2.69M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 2.05M | SH | $36.04M 2.70% | 2.05M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 4.76M | SH | $34.14M 2.56% | 4.76M | 0.00 | 0.00 |
JADE BIOSCIENCES INCSOLE | COM NEW | 3.22M | SH | $32.17M 2.41% | 3.22M | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INCSOLE | COM | 13.97M | SH | $31.71M 2.38% | 13.97M | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM NEW | 639.09K | SH | $31.13M 2.33% | 639.09K | 0.00 | 0.00 |
UPSTREAM BIO INCSOLE | COM | 2.30M | SH | $25.20M 1.89% | 2.30M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 17.86M | SH | $22.68M 1.70% | 17.86M | 0.00 | 0.00 |
CRESCENT BIOPHARMA INC.SOLE | COM | 1.39M | SH | $22.40M 1.68% | 1.39M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.17M | SH | $20.70M 1.55% | 2.17M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 8.88M | SH | $20.26M 1.52% | 8.88M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 1M | SH | $18.63M 1.40% | 1M | 0.00 | 0.00 |
ENGENE HOLDINGS INCSOLE | COM | 5.05M | SH | $18.37M 1.38% | 5.05M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 2.46M | SH | $13.17M 0.99% | 2.46M | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCSOLE | COM | 1.38M | SH | $10.39M 0.78% | 1.38M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 1.35M | SH | $10.30M 0.77% | 1.35M | 0.00 | 0.00 |
PERCEPTIVE CAP SOLUTIONS CORSOLE | CL A ORD SHS | 750K | SH | $7.96M 0.60% | 750K | 0.00 | 0.00 |
Page 1 of 2